News | Ultrasound Women's Health | July 11, 2019

FDA Clears Koios DS Breast 2.0 AI-based Software

Machine learning-based software offers proprietary alignment to BI-RADS for any lesion analyzed, and is available connected to PACS and/or directly on GE Healthcare's Logiq E10 ultrasound system

FDA Clears Koios DS Breast 2.0 AI-based Software

July 11, 2019 — Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Koios DS (Decision Support) Breast 2.0 is intended for use to assist physicians analyzing breast ultrasound images. It aligns a machine learning-generated probability of malignancy with the appropriate BI-RADS (Breast Imaging-Reporting and Data System) category.

The software is cleared for use at the point of care, or connected to an image viewer for studies stored on picture archiving and communication systems (PACS). According to the company, Koios DS Breast 2.0 represents the most advanced artificial intelligence (AI)-based diagnostic technology for ultrasound image analysis to date. This patented software uses an ensemble of algorithms to aid the early detection of disease while also reducing biopsies of benign tissue.

In a recent reader study involving 15 physicians with relevant experience up to 39 years, each randomly analyzed 900 cases twice, separated by a one-month "washout period."  Physicians utilizing the Koios DS 2.0 AI software experienced a statistically significant improvement in accuracy as measured by area under the receiver operating characteristic (ROC) curve, while simultaneously reducing both inter- and intra-operator variability.

Koios DS Breast 2.0 can be used in conjunction with most major PACS platforms and is directly available on the next-generation Logiq E10 digital ultrasound system from GE Healthcare. The Logiq E10 integrates AI, cloud connectivity, and advanced algorithms to acquire and reconstruct data. Machine-generated results can be exported directly into a patient's record. 

Koios Medical continues to experiment with thyroid ultrasound image data and expects to add to its offering later this year.

For more information: www.koiosmedical.com

Related Content

Ways to Increase Productivity and Efficiency in Breast Imaging

Development of Artificial Intelligence in Women’s Health Emphasizes Value

Technology to Watch in Breast Imaging

Related Content

Sponsored Content | Videos | Artificial Intelligence | February 21, 2020
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intel
An example of the MRI scans showing long-term and short-term survival indications. #MRI

An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — ...
Sponsored Content | Videos | Enterprise Imaging | February 19, 2020
Bill Lacy, vice president, Medical Informatics at FUJIFILM Medic...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
PaxeraHealth enterprise imaging, PACS, VNA solutions
News | Enterprise Imaging | February 11, 2020
February 11, 2020 — Enterprise Imaging developer PaxeraHealth
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...